The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.


Amgen Inc

Nasdaq: AMGN


Today's change-- --
 Delayed by at least 15 minutes.

Amgen Inc

Nasdaq: AMGN


Today's change-- --
Updated January 1 -- GMT. Delayed by at least 15 minutes.

Amgen Inc unchanged

Amgen Inc closed unchanged Friday sitting at (U.S.)$0.00. This security is unchanged over the last five days and the last 52 weeks. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open--
  • Previous close--
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change--
  • Volume--
  • Average volume (10-day)--
  • Average volume (1-month)--
  • Average volume (3-month)--
  • 52-week range-- to --
  • Beta--
  • Trailing P/E--
  • P/E 1 year forward17.58×
  • Forward PEG1.54×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
Updated January 1 -- GMT. Delayed by at least 15 minutes.


Net Profit (TTM)

Based on its net profit margin of 27.74%, Amgen Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Total other revenue--------
Total revenue5,3315,0315,1804,521
Gross profit4,1484,1624,3023,431
Total cost of revenue1,1838698781,090
Total operating expense3,8723,5653,2783,157
Selling / general / administrative1,3271,2131,1361,023
Research & development1,2341,0181,0181,027
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)9529226--
Other operating expenses, total119-642017
Operating income1,4591,4661,9021,364
Interest income (expense), net non-operating-261-269-282-259
Gain (loss) on sale of assets--------
Income before tax1,2861,3371,7581,204
Income after tax1,2941,2441,5471,073
Income tax, total-893211131
Net income1,2941,2441,5471,073
Total adjustments to net income--------
Net income before extra. items1,2941,2441,5471,073
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2941,2441,5471,073
Inc. avail. to common incl. extra. items1,2941,2441,5471,073
Diluted net income1,2941,2441,5471,073
Dilution adjustment--0----
Diluted weighted average shares773771768768
Diluted EPS excluding extraordinary itemsvalue per share1.671.612.011.40
Dividends per sharevalue per share0.610.610.610.61
Diluted normalized EPSvalue per share1.682.252.271.40